tiprankstipranks
Trending News
More News >
Bio-Gene Technology Ltd. (AU:BGT)
ASX:BGT
Australian Market
Advertisement

Bio-Gene Technology Ltd. (BGT) Stock Statistics & Valuation Metrics

Compare
7 Followers

Total Valuation

Bio-Gene Technology Ltd. has a market cap or net worth of AU$8.24M. The enterprise value is AU$2.54M.
Market CapAU$8.24M
Enterprise ValueAU$2.54M

Share Statistics

Bio-Gene Technology Ltd. has 305,061,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding305,061,100
Owned by Insiders
Owned by Institutions

Financial Efficiency

Bio-Gene Technology Ltd.’s return on equity (ROE) is -1.59 and return on invested capital (ROIC) is -154.30%.
Return on Equity (ROE)-1.59
Return on Assets (ROA)-1.20
Return on Invested Capital (ROIC)-154.30%
Return on Capital Employed (ROCE)-1.87
Revenue Per Employee
Profits Per Employee-10.00T>
Employee Count
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Bio-Gene Technology Ltd. is ―. Bio-Gene Technology Ltd.’s PEG ratio is 0.21.
PE Ratio
PS Ratio0.00
PB Ratio2.08
Price to Fair Value2.08
Price to FCF-1.33
Price to Operating Cash Flow-4.55
PEG Ratio0.21

Income Statement

In the last 12 months, Bio-Gene Technology Ltd. had revenue of 0.00 and earned -2.58M in profits. Earnings per share was -0.01.
Revenue0.00
Gross Profit-245.78K
Operating Income-3.07M
Pretax Income-2.58M
Net Income-2.58M
EBITDA-2.58M
Earnings Per Share (EPS)-0.01

Cash Flow

In the last 12 months, operating cash flow was -1.71M and capital expenditures 0.00, giving a free cash flow of -1.71M billion.
Operating Cash Flow-1.71M
Free Cash Flow-1.71M
Free Cash Flow per Share>-0.01

Dividends & Yields

Bio-Gene Technology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.22
52-Week Price Change-50.00%
50-Day Moving Average0.03
200-Day Moving Average0.03
Relative Strength Index (RSI)50.46
Average Volume (3m)988.87K

Important Dates

Bio-Gene Technology Ltd. upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 25, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date

Financial Position

Bio-Gene Technology Ltd. as a current ratio of 3.86, with Debt / Equity ratio of 3.15%
Current Ratio3.86
Quick Ratio3.86
Debt to Market Cap0.02
Net Debt to EBITDA0.42
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Bio-Gene Technology Ltd. has paid -385.63K in taxes.
Income Tax-385.63K
Effective Tax Rate0.15

Enterprise Valuation

Bio-Gene Technology Ltd. EV to EBITDA ratio is -0.89, with an EV/FCF ratio of -0.90.
EV to Sales0.00
EV to EBITDA-0.89
EV to Free Cash Flow-0.90
EV to Operating Cash Flow-0.90

Balance Sheet

Bio-Gene Technology Ltd. has AU$1.14M in cash and marketable securities with AU$51.21K in debt, giving a net cash position of AU$1.09M billion.
Cash & Marketable SecuritiesAU$1.14M
Total DebtAU$51.21K
Net CashAU$1.09M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Bio-Gene Technology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score7
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis